Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$30,943,164
+$4,823,268 QoQ
Shares Held
122,966
+2.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#475
of 4,152 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crestwood Advisors Group, LLC holds $223,873,417 across 13 Drug Manufacturers - General names. ABBV ranks #4 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
268,723 | $68,247,580 | |
| 2 | LLY |
ELI LILLY & Co
|
44,320 | $53,158,741 | |
| 3 | AZN |
Astrazeneca PLC
|
224,312 | $42,534,041 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
122,966 | $30,943,164 | |
| 5 | MRK |
Merck & Co., Inc.
|
114,219 | $14,677,141 | |
| 6 | AMGN |
Amgen Inc
|
14,249 | $5,159,847 | |
| 7 | PFE |
Pfizer Inc
|
137,811 | $3,318,488 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
20,797 | $2,627,492 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,943,164 | 122,966 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $26,119,896 | 120,097 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $27,239,891 | 119,217 | Shares | Other | 2026-02-03 | |
| 2025-09-30 | $27,788,041 | 120,014 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $21,919,680 | 118,089 | Shares | Other | 2025-08-05 | |
| 2025-03-31 | $24,952,365 | 119,093 | Shares | Other | 2025-05-05 | |
| 2024-12-31 | $20,083,831 | 113,021 | Shares | Other | 2025-02-04 | |
| 2024-09-30 | $21,864,195 | 110,716 | Shares | Other | 2024-10-30 | |
| 2024-06-30 | $18,706,657 | 109,064 | Shares | Other | 2024-08-01 | |
| 2024-03-31 | $19,901,526 | 109,289 | Shares | Other | 2024-05-08 | |
| 2023-09-30 | $16,441,914 | 110,304 | Shares | Other | 2023-11-15 | |
| 2023-06-30 | $1,684,798 | 12,505 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,836,420 | 11,523 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,119,515 | 13,115 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,918,934 | 14,298 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $2,170,583 | 14,172 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $2,558,906 | 15,785 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $2,280,813 | 16,845 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,287,212 | 11,933 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,286,123 | 11,418 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,189,121 | 10,988 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $1,229,974 | 11,479 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $926,789 | 10,581 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $907,477 | 9,243 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $657,672 | 8,632 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||